Donate
Blue Square Marketing
17 - 30 Jun 2019

Pritesh Gohil - Hike

profile picture
Pritesh Gohil

Total raised

£137.50

+ £31.88 Gift Aid

Donate

Donating through this page is simple, fast and totally secure. Your details are safe with Cancer Research UK

Proud to support Cancer Research UK

With a decade’s experience helping some of the world’s biggest brands, we, Blue Square Marketing, are an industry-leading field and experiential marketing agency that accelerate brand performance.

This year our staff have chosen to support Cancer Research UK. Thanks to research, cancer survival has doubled in the last 40 years, with 1 in 2 now beating their disease. But there is still so much to do. Today around 910 people will be diagnosed with cancer and half of them sadly will not survive their disease. With our help, Cancer Research UK can pursue their ambition to accelerate progress and see three-quarters of people surviving cancer within the next 20 years. Thank you for your support.

Latest updates

O

Owen Bailey

2019-06-22T11:21:06+00:00

£5.00

+£1.25 Gift Aid

Good luck Pri!

H

Harry Cater

2019-06-22T10:33:45+00:00

£5.00

+£1.25 Gift Aid

Good luck Pri

J

Joe Williams

2019-06-22T10:01:41+00:00

£5.00

Good luck Pri’s be safe

H

Hena Gohil

2019-06-22T04:17:49+00:00

£15.00

+£3.75 Gift Aid

All the best xx

F

Freddie

2019-06-21T06:04:35+00:00

£5.00

+£1.25 Gift Aid

Good luck, Pri!

T

Tayla Modeste

2019-06-20T17:06:30+00:00

£10.00

+£2.50 Gift Aid

Total raised£137.50

Online£137.50

Offline£0.00

With Cancer Research UK Giving Pages more of the money raised goes towards beating cancer sooner. Aside from the credit and debit card fees, every penny donated goes to Cancer Research UK.

All donations made to this page will automatically be transferred to Cancer Research UK.

Cause

Childhood cancer

Each year, around 1,500 children are diagnosed with cancer in the UK. Thanks to major advances in research, around three-quarters of children with cancer now survive. Help Cancer Research UK discover better and kinder treatments for all cancers and to continue to improve overall survival for childhood cancer.